Literature DB >> 8695016

Insulin and blood pressure among healthy children. Cardiovascular risk in young Finns.

L Taittonen1, M Uhari, M Nuutinen, J Turtinen, T Pokka, H K Akerblom.   

Abstract

We evaluated the role of insulin in regulating and predicting blood pressure among 3596 to 2799 Finnish children and adolescents aged 3 to 18 years who were followed from 1980 to 1986. Blood pressure, weight, and height were measured in three surveys 3 years apart. Fasting blood samples were drawn and serum insulin was analyzed. The effect of insulin on blood pressure was evaluated in each of the 3 study years, together with the effect of fasting insulin on future blood pressure and the effect of insulin on the change in blood pressure. We also analyzed the correlation between insulin and blood pressure in different age groups and the correlation between change in insulin and change in blood pressure. A constant positive correlation was found between insulin and both systolic and diastolic (Korotkoff's fifth phase) blood pressures measured in the respective years (correlation coefficients 0.10 to 0.41 and partial correlation coefficients 0.02 to 0.15), except between insulin and diastolic blood pressure in the first two surveys in terms of partial correlation and multiple regression analysis. Similarly insulin and blood pressure correlated positively in every age group. Insulin measured in 1980 or 1983 predicted systolic blood pressure as measured 3 and 6 years later (correlation coefficients 0.30 to 0.47 and partial correlation coefficients 0.06 to 0.13), and likewise diastolic blood pressure as measured 3 and 6 years later (correlation coefficients 0.17 to 0.35 and partial correlation coefficients 0.05 to 0.08), except among the males in 1983. Correlation between insulin and the change in blood pressure was not significant or remained marginal. Similarly, the correlation between change in insulin and change in blood pressure was not significant or remained marginal. We suggest that insulin seems to regulate actual blood pressure within the normal range and to predict future blood pressure among children and adolescents, independently of age and weight. However, insulin does not enhance the rise in blood pressure.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8695016     DOI: 10.1016/0895-7061(95)00345-2

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  14 in total

1.  Cross-sectional association between blood pressure, in vivo insulin sensitivity and adiponectin in overweight adolescents.

Authors:  Javier De Las Heras; Sojung Lee; Fida Bacha; Hala Tfayli; Silva Arslanian
Journal:  Horm Res Paediatr       Date:  2011-09-30       Impact factor: 2.852

2.  Increased C-reactive protein is associated with future development of diabetes mellitus in essential hypertensive patients.

Authors:  Chiung-Mei Weng; Chang-Hua Chou; Yao-Yi Huang; Chih-Chan Lin; Yen-Wen Liu; Wei-Chuan Tsai
Journal:  Heart Vessels       Date:  2010-07-31       Impact factor: 2.037

Review 3.  Childhood obesity and cardiovascular disease: links and prevention strategies.

Authors:  Kristen J Nadeau; David M Maahs; Stephen R Daniels; Robert H Eckel
Journal:  Nat Rev Cardiol       Date:  2011-06-14       Impact factor: 32.419

4.  Pediatric nonalcoholic fatty liver disease: A clinical and laboratory challenge.

Authors:  Lucia Pacifico; Eleonora Poggiogalle; Vito Cantisani; Guendalina Menichini; Paolo Ricci; Flavia Ferraro; Claudio Chiesa
Journal:  World J Hepatol       Date:  2010-07-27

Review 5.  Role of hypertension in the metabolic syndrome: who is affected?

Authors:  Gladys Velarde; Bradford C Berk
Journal:  Curr Hypertens Rep       Date:  2005-12       Impact factor: 5.369

Review 6.  Cardiovascular and Metabolic Complications - Diagnosis and Management in Obese Children.

Authors:  Naval K Vikram
Journal:  Indian J Pediatr       Date:  2017-12-08       Impact factor: 1.967

7.  Blood pressure from childhood to adolescence in obese youths in relation to insulin resistance and asymmetric dimethylarginine.

Authors:  T de Giorgis; M L Marcovecchio; C Giannini; V Chiavaroli; F Chiarelli; A Mohn
Journal:  J Endocrinol Invest       Date:  2015-07-16       Impact factor: 4.256

Review 8.  Integrating anthropometric and cardiometabolic health methods in stress, early experiences, and development (SEED) science.

Authors:  Jenalee R Doom; Brie M Reid; Emily Nagel; Sheila Gahagan; Ellen W Demerath; Julie C Lumeng
Journal:  Dev Psychobiol       Date:  2020-09-09       Impact factor: 3.038

Review 9.  Hypertension and the cardiometabolic syndrome.

Authors:  Camila Manrique; Guido Lastra; Adam Whaley-Connell; James R Sowers
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-08       Impact factor: 3.738

Review 10.  Insulin resistance, hypertension, and coronary heart disease.

Authors:  Gerald Reaven
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 Jul-Aug       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.